A Phase I/II Study of Dasatinib and Dacarbazine
Clinical trial NCT00597038 · COMPLETED
Trial details
- NCT number
- NCT00597038
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2011-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.